Cargando…
Randomised, Double-Blind, Placebo-Controlled Study of Iguratimod in the Treatment of Active Spondyloarthritis
Background and Purpose: The effect of Iguratimod in the treatment of rheumatoid arthritis was confirmed in past studies. In terms of the mechanism of the effect and clinical application experience, Iguratimod has a potential value in the treatment of spondyloarthritis (SpA). This study evaluated the...
Autores principales: | Li, Yan, Li, Kunpeng, Zhao, Zheng, Wang, Yanyan, Jin, Jingyu, Guo, Junhua, Zhang, Jie, Zhang, Jianglin, Zhu, Jian, Huang, Feng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8208078/ https://www.ncbi.nlm.nih.gov/pubmed/34150809 http://dx.doi.org/10.3389/fmed.2021.678864 |
Ejemplares similares
-
Comparative Analysis of Clinical and Imaging Features of Osteomalacia and Spondyloarthritis
por: Zhao, Zheng, et al.
Publicado: (2021) -
Efficacy and safety of suanzaoren decoction for chronic insomnia disorder in adults: study protocol for randomised, double-blind, double-dummy, placebo-controlled trial
por: Zhou, Qi-Hui, et al.
Publicado: (2017) -
Iguratimod as an alternative therapy for systemic sclerosis and prevention of the occurrence of ischemic digital ulcer
por: Yan, Qingran, et al.
Publicado: (2023) -
Gout mimicking spondyloarthritis: case report and literature review
por: Chen, Wenji, et al.
Publicado: (2017) -
Preparation of a Major Metabolite of Iguratimod and Simultaneous Assay of Iguratimod and Its Metabolite by HPLC in Rat Plasma
por: Han, Jun-ping, et al.
Publicado: (2019)